ArticleMolecular therapy. Advances2026
Optimizing single molecule, real-time sequencing for enhanced characterization of adeno-associated viral vector genomes.
Article in Molecular therapy. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monitoring the payload of recombinant adeno-associated viral vectors (rAAVs) used for gene therapy applications is essential. Long-read sequencing is a promising method to confirm not only the identity of the packaged DNA but also to assess its integrity with regard to truncations, deletions, insertions, and chimeras. Given its high accuracy, even in regions that are notoriously difficult to sequence, such as the rAAV's inverted-terminal repeats, single molecule, real-time (SMRT) sequencing by Pacific Biosciences might be well suited for quality control purposes. However, the library preparation workflow involves multiple steps that could potentially introduce biases and thereby misrepresent the sample composition. Here, we present a systematic study investigating the influence of several steps on the quality of the output data. Based on these insights, we introduce an adapted protocol to enhance the SMRT technology for accurate and reproducible in-depth characterization of the ssDNA payload in rAAVs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.